September 24, 2025
Munich, Germany
Berenberg and Goldman Sachs 14th German Corporate Conference
September 18, 2025
Frankfurt, Germany
Barclays 2025 EU MedTech & Life Sciences Investor Trip
September 10, 2025
New York, USA
Morgan Stanley 23rd Annual Global Healthcare Conference
September 03, 2025
London, UK
Goldman Sachs 22nd Annual Medtech and Healthcare Services Conference
Fresenius Digital Technology Polska sp. z o.o., with its registered office in Wrocław (address: pl. Nowy Targ 28, 50-141 Wrocław), entered into the Register of Entrepreneurs of the National Court Register maintained by the District Court for Wrocław-Fabryczna in Wrocław, 6th Commercial Division of the National Court Register under KRS number 0000914913, NIP 8943171759, with a share capital of PLN 135,000.00, is represented by the Management Board acting in accordance with the rules of representation disclosed in the National Court Register.
We are committed to maintaining the highest standards of ethics and integrity. In accordance with Polish regulations, individuals can confidentially report any suspected violations, unethical behavior or compliance issues through the following channels:
Email: sygnalisci@fresenius.com
Group Whistleblowing Channel: Our grievance mechanism | FSE
All reports are handled with strict confidentiality and in line with applicable data protection laws. Retaliation against whistleblowers is strictly prohibited.